LONDON, Dec 1 (Reuters) - AstraZeneca has signed a wide-ranging deal with private biotech firm Bicycle Therapeutics to develop a novel class of small molecule medicines for treating respiratory, cardiovascular and metabolic diseases.
from Reuters: New Issues News http://ift.tt/2gCfIyK
Tidak ada komentar:
Posting Komentar